UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

July 22, 2026

Commission File Number: 000-17444

 

 

Akzo Nobel N.V.

 

 

Christian Neefestraat 2

1077 WW Amsterdam

The Netherlands

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒   Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

The following exhibit is furnished herewith:

EXHIBIT INDEX

 

Exhibit Number		Description of Exhibit
99.1		Q2 Report 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

				AKZO NOBEL N.V.
Date: July 22, 2026				By:		/s/ Grégoire Poux-Guillaume
						Name:  Grégoire Poux-Guillaume
						Title:   Chief Executive Officer
Date: July 22, 2026				By:		/s/ Maarten de Vries
						Name:  Maarten de Vries
						Title:   Chief Financial Officer